Manufacturing

What Is the Future of the Cell and Gene Therapy Market?
Research & Development What Is the Future of the Cell and Gene Therapy Market?

Specialized logistics firms like Cryoport Inc. held a 4% market share in 2025, highlighting the critical role of cold chain infrastructure in transporting temperature-sensitive live cell products. This reality emphasizes a profound shift within the pharmaceutical sector, where the focus is

Can Automation Solve the Challenges of Modern IVF?
Tech & Innovation Can Automation Solve the Challenges of Modern IVF?

Current IVF protocols often treat all retrieved eggs as a single cohort despite the biological reality that every egg matures at a different rate with unique metabolic needs. For decades, the process of in vitro fertilization has remained a high-stakes endeavor characterized by manual intensity and

KU Researchers Develop Nanochip for Early Disease Detection
Tech & Innovation KU Researchers Develop Nanochip for Early Disease Detection

U.S. Senator Jerry Moran has advocated for the project, noting that investments in such research are vital for maintaining national scientific leadership and improving patient outcomes. This sentiment underscores a major initiative at the University of Kansas, where a team led by Foundation

New PCR Platform Improves Biosecurity Testing for Aquafeeds
Management & Regulatory New PCR Platform Improves Biosecurity Testing for Aquafeeds

White Spot Syndrome Virus serves as a critical proof-of-concept model for testing how long-fragment PCR can improve the accuracy of feed safety evaluations. The rapid expansion of the global shrimp aquaculture industry has reached a pivotal juncture in 2026, where the volume of production must be

Alcon Acquires Neurotech Pharmaceuticals for $550 Million
Management & Regulatory Alcon Acquires Neurotech Pharmaceuticals for $550 Million

Rare retinal diseases like MacTel often lead to the development of abnormal blood vessels and the permanent loss of clear central vision. This challenging medical reality has prompted Alcon, a global leader in eye care, to enter into a definitive agreement to acquire Neurotech Pharmaceuticals for

Dr. Hans-Peter Kiem Leads the Future of Gene and Cell Therapy
Research & Development Dr. Hans-Peter Kiem Leads the Future of Gene and Cell Therapy

Dr. Hans-Peter Kiem’s early medical training at the University of Ulm laid the groundwork for his future breakthroughs in the regenerative potential of hematopoietic stem cells. This fascination with the building blocks of the blood system eventually propelled him to the forefront of translational

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later